Post-approval studies (Phase 4)UnknownNCT03107078
What this trial is testing
Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial
Who this might be right for
Thyroid Associated Ophthalmopathy
Jie Shen 200